Kashi Raj Bhattarai, PhD1,2*, Kelly R. Barnett, PhD1,2*, Robert J. Mobley, PhD3,4*, Daniel C. Ferguson, PhD1,2*, Jonathan D. Diedrich, PhD1,4*, Brennan P. Bergeron, MS1,2,5*, Wenjian Yang, PhD1,2*, Kristine R. Crews, PharmD1,2*, Wendy Stock, MD6, Elisabeth Paietta, PhD7*, Steven M. Kornblau, MD8, Hiroto Inaba, MD, PhD1,9, Sima Jeha, MD1,9, Ching-Hon Pui, MD1,10, Cheng Cheng, PhD11*, Mary V. Relling, PharmD1,2, William E. Evans, PharmD1,2, Jun J. J. Yang, PhD1,4,5,12 and Daniel Savic, PhD1,2,5,12
1Hematological Malignancies Program and Center for Precision Medicine in Leukemia, St. Jude Children's Research Hospital, Memphis, TN
2Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN
3Hematological Malignancies Program and Center for Precision Medicine in Leukemia, St. Jude Children’s Research Hospital, Memphis, TN
4Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, TN
5Graduate School of Biomedical Sciences, St. Jude Children's Research Hospital, Memphis, TN
6Comprehensive Cancer Center, University of Chicago Medicine, Chicago, IL
7Albert Einstein College of Medicine, New York, NY
8Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
9Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN
10Department of Oncology, St. Jude Children's Rsch./Hosp., Memphis, TN
11Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN
12Integrated Biomedical Sciences Program, University of Tennessee Health Science Center, Memphis, TN